Coronavirus Update:What patients and families need to know
Bone Marrow Transplant and Cell Therapy Fellowship
Training at a Top Ranked Cancer Hospital
Children's National Hospital is consistently ranked nationally as a top 10 pediatric hospital by U.S. News & World Report, as well as a leading institution for cancer research.
The goal of the Bone Marrow Transplant and Cell Therapy (BMTCT) Fellowship at Children’s National Hospital is to provide well-rounded clinical and laboratory training for fellows interested in transplant and cellular therapy.
The National Institutes of Health (NIH) and Children’s National Hospital (CNH) are now recruiting candidates for a one-year fellowship. The overall objective is to give BMTCT fellows extensive experience in clinical management by being assigned primary patients, and following them from initial consult and eligibility criteria through their inpatient and outpatient management.
Fellows will also gain valuable experience by functioning as medical coverage and, eventually, providing primary oversight over the BMT unit patients. They will work within an interdisciplinary team that consists of a BMT faculty member, hematology/oncology fellows, subspecialist consultants, nurse practitioners, physician assistants, pediatric house staff, medical students, inpatient nurses, social work, psychology, case manager, nutritionist and other members of the inpatient and outpatient health care teams.
Ideal applicants will need to have:
- Completed a fellowship in Hematology/Oncology
- Completed board-certification or be eligible
- Been involved with a research track demonstrating interest in BMTCT-associated themes
Fellows will split their time equally between the National Institutes of Health and Children's National Hospital, both serve as tertiary referral centers in the region and the world, giving access to medically complex and quite diverse patient population. Fellows will be involved in both inpatient and outpatient management of a myriad of diseases, including:
- Malignant diseases
- Primary immunodeficiencies
- Bone marrow failure syndromes
- Cellular therapy (including CAR-T, viral and tumor specific therapies, mesenchymal stromal cells, among others)
Fellows will be exposed to cutting-edge clinical and translational research, which include multiple chimeric antigen receptor products, gene therapy, cytotoxic T cell therapies and multi-institutional transplant therapy trials. It is expected that each fellow will have a research goal that will be developed during their time in the BMTCT Fellowship.
In addition to direct patient care in both institutions, fellows will be strongly encouraged to participate in rotations with ancillary divisions. Rotations will be tailored to the fellow’s future plans, including:
How to Apply
Please submit a resume, personal statement and letters of recommendation (two letters required, three preferred) to Blachy Davila Saldana, M.D., and Lea Cunningham, M.D. Review of applications will continue until the position is filled.
To learn more about the Bone Marrow Transplant and Cell Therapy Fellowship, please call 202-476-6690 or email Fellowship Coordinator Marsha Thomas.